In alignment with these observations, the present study revealed that CXCL3 expression is significantly elevated in liver cancer tissues and is associated with more advanced clinical staging and reduced overall survival, indicating that CXCL3 may contribute to liver cancer development. This evidence concerns the gene CXCL3 and liver cancer.